Meghan Lawler

Meghan is a creative biochemist with experience ranging from peptide synthesis to SELEX to lncRNA footprinting. While pursuing her PhD at Duke University, she employed each of these with protein biochemistry to explore dynamic interactions of epigenetic complexes. Afterwards, she joined the DEL selections team at GSK where she learned to translate her experiences into the DEL world. Meghan has a natural drive to explore and at Anagenex is developing new approaches to the wide variety of biochemical problems in the DEL space.